Algorae Pharmaceuticals Limited (ASX:1AI)
Australia flag Australia · Delayed Price · Currency is AUD
0.0130
-0.0010 (-7.14%)
Mar 10, 2026, 4:10 PM AEST

Algorae Pharmaceuticals Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2020 - 2016
Market Capitalization
2481723107
Upgrade
Market Cap Growth
103.03%-50.00%-27.90%127.61%49.95%0.11%
Upgrade
Enterprise Value
226132065
Upgrade
Last Close Price
0.010.010.010.010.010.01
Upgrade
PS Ratio
----3019.5725.57
Upgrade
PB Ratio
12.693.795.606.222.554.98
Upgrade
P/TBV Ratio
12.693.795.606.222.554.98
Upgrade
EV/Sales Ratio
----1723.9917.81
Upgrade
Net Debt / Equity Ratio
-1.00-1.04-1.03-1.09-1.05-1.17
Upgrade
Net Debt / EBITDA Ratio
--1.822.702.911.21
Upgrade
Net Debt / FCF Ratio
2.682.952.042.072.071.10
Upgrade
Asset Turnover
----0.000.11
Upgrade
Quick Ratio
17.1813.9017.669.3517.846.13
Upgrade
Current Ratio
17.9914.1317.899.3517.846.13
Upgrade
Return on Equity (ROE)
-47.38%-30.63%-61.85%-54.06%-72.33%-68.64%
Upgrade
Return on Assets (ROA)
-40.34%-23.85%-28.78%-22.41%-30.84%-33.30%
Upgrade
Return on Capital Employed (ROCE)
-77.50%-47.90%-56.60%-40.40%-36.20%-97.40%
Upgrade
Earnings Yield
-4.23%-9.52%-12.42%-9.01%-19.04%-21.30%
Upgrade
FCF Yield
--9.31%-9.03%-8.49%-19.90%-21.32%
Upgrade
Buyback Yield / Dilution
-4.60%-1.46%-23.47%-53.82%-53.24%-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.